| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | interphotoreceptor matrix | 7.70e-05 | 6 | 48 | 2 | GO:0033165 | |
| Domain | RetinoicA-induced_16-like | 3.87e-05 | 4 | 48 | 2 | IPR019384 | |
| Domain | RAI16-like | 3.87e-05 | 4 | 48 | 2 | PF10257 | |
| Domain | C-type_lectin_CS | 5.46e-03 | 43 | 48 | 2 | IPR018378 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 23178534 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 26792863 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | FAM114A1 DPYSL2 APPL2 RUVBL1 NRDC PDLIM1 MTHFD1 PSMD2 TP53RK CHORDC1 | 3.54e-05 | 1455 | 50 | 10 | 22863883 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 4.74e-05 | 1201 | 50 | 9 | 35696571 | |
| Pubmed | The small-subunit processome is a ribosome assembly intermediate. | 5.64e-05 | 8 | 50 | 2 | 15590835 | |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 5.64e-05 | 8 | 50 | 2 | 12634303 | |
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 19433865 | ||
| Pubmed | 7.64e-05 | 156 | 50 | 4 | 37108203 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 8.37e-05 | 736 | 50 | 7 | 29676528 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 8.96e-05 | 315 | 50 | 5 | 26777405 | |
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 9.71e-05 | 166 | 50 | 4 | 35687106 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 9.85e-05 | 1024 | 50 | 8 | 24711643 | |
| Pubmed | Quantitative interaction proteomics of neurodegenerative disease proteins. | 1.01e-04 | 323 | 50 | 5 | 25959826 | |
| Pubmed | 1.55e-04 | 565 | 50 | 6 | 20458337 | ||
| Pubmed | 1.55e-04 | 72 | 50 | 3 | 34882091 | ||
| Pubmed | 1.56e-04 | 13 | 50 | 2 | 32073997 | ||
| Pubmed | 1.80e-04 | 1431 | 50 | 9 | 37142655 | ||
| Pubmed | 1.90e-04 | 1442 | 50 | 9 | 35575683 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 2.08e-04 | 853 | 50 | 7 | 28718761 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 3.67e-04 | 235 | 50 | 4 | 30258100 | |
| Pubmed | The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression. | 3.75e-04 | 97 | 50 | 3 | 37151849 | |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | 4.84e-04 | 454 | 50 | 5 | 33226137 | |
| Pubmed | Identification of FBXO25-interacting proteins using an integrated proteomics approach. | 5.71e-04 | 112 | 50 | 3 | 20473970 | |
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | 6.09e-04 | 269 | 50 | 4 | 30442662 | |
| Pubmed | 6.35e-04 | 272 | 50 | 4 | 31010829 | ||
| Pubmed | 6.95e-04 | 27 | 50 | 2 | 21320693 | ||
| Pubmed | 7.29e-04 | 497 | 50 | 5 | 23414517 | ||
| Pubmed | 7.85e-04 | 125 | 50 | 3 | 29467281 | ||
| Pubmed | 1.06e-03 | 312 | 50 | 4 | 37120454 | ||
| Pubmed | 1.14e-03 | 549 | 50 | 5 | 38280479 | ||
| Pubmed | 1.24e-03 | 36 | 50 | 2 | 31669268 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 1.28e-03 | 564 | 50 | 5 | 21565611 | |
| Pubmed | 1.32e-03 | 568 | 50 | 5 | 37774976 | ||
| Pubmed | 1.41e-03 | 153 | 50 | 3 | 27462432 | ||
| Cytoband | 1p22.3 | 2.65e-04 | 22 | 50 | 2 | 1p22.3 | |
| Cytoband | 4p14 | 9.73e-04 | 42 | 50 | 2 | 4p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p14 | 2.46e-03 | 67 | 50 | 2 | chr4p14 | |
| ToppCell | COVID-19-kidney-Technical/muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.80e-05 | 139 | 50 | 4 | 13247bcb21c57c808657e0f543d6f134eeea7cc1 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 2.30e-05 | 148 | 50 | 4 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 150 | 50 | 4 | 9cb3332924bd67c966873343c14445e30d3f384f | |
| ToppCell | 3'_v3-blood-Lymphocytic_B-ABC_aged-B_memory|blood / Manually curated celltypes from each tissue | 3.78e-05 | 168 | 50 | 4 | 2ce1a30feb2704a9516d1dab161a26cb0555abb5 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.43e-05 | 175 | 50 | 4 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.43e-05 | 175 | 50 | 4 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | COVID-19_Moderate-B_intermediate|COVID-19_Moderate / disease group, cell group and cell class | 4.63e-05 | 177 | 50 | 4 | 68e3d12a0c048a2d0f1b9680c7338a35855bba30 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-05 | 177 | 50 | 4 | a68c3688f12aee22f3cb4049c4bccacbacb0fae6 | |
| ToppCell | B_cells-ABCs|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.27e-05 | 183 | 50 | 4 | bf9c6fe3ce4e44e4056027257eab8448c39c4fb8 | |
| ToppCell | Mild/Remission-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.38e-05 | 184 | 50 | 4 | 3d4864605c812862cf8926e02370eea3b8ccf32f | |
| ToppCell | PND01-03-samps-Epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.50e-05 | 185 | 50 | 4 | 2b854df79cfe2cb4d2f9c2938a066e0aa3649325 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.73e-05 | 187 | 50 | 4 | 23fe3cdd6cc9b067086a8392d104186d300298ea | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.85e-05 | 188 | 50 | 4 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.22e-05 | 191 | 50 | 4 | 6a8b0987e75456a257954288206da0032605ff2a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.22e-05 | 191 | 50 | 4 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | VE-naiveBc-|VE / Condition, Cell_class and T cell subcluster | 6.35e-05 | 192 | 50 | 4 | bca2aec4811627225fccd92abe2f3b1ba729c9ce | |
| ToppCell | VE-naiveBc|VE / Condition, Cell_class and T cell subcluster | 6.35e-05 | 192 | 50 | 4 | 87cdda9a170f6f2fa56d0ed1d3fd2f93bfe09aa1 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.74e-05 | 195 | 50 | 4 | d673f8844896d5c7b76a7bc7f6b88a039f1bc263 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Non-resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.74e-05 | 195 | 50 | 4 | ee8743d39996bb756f50db32748e8a902d3294b8 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.88e-05 | 196 | 50 | 4 | 28e9e191361966df3a9bd48450090577aa72a999 | |
| ToppCell | distal-1-Hematologic-Interstitial_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.01e-05 | 197 | 50 | 4 | 9e5df74aeeefa4d928ec07c036aacb549c797f30 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.01e-05 | 197 | 50 | 4 | 7293587c875738c1711b8a68d40303a197b01c32 | |
| ToppCell | Mild/Remission-B_intermediate-6|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.01e-05 | 197 | 50 | 4 | 5370dda4a25e3a53d6fe2c887b7dabd7a58462b4 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.01e-05 | 197 | 50 | 4 | 82072bd73634e1ef24dc193e860af7786727313b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.01e-05 | 197 | 50 | 4 | b4869013f0523ac73c284e6cdaf64e9ae5213dc5 | |
| ToppCell | PCW_13-14-Epithelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.15e-05 | 198 | 50 | 4 | 48eb6f69a464a34ab32e8d425a22b9d45ec20428 | |
| ToppCell | Transplant_Alveoli_and_parenchyma|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.29e-05 | 199 | 50 | 4 | 44bd36a62f06058c5d09feec6e96ecaf310f4791 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-05 | 199 | 50 | 4 | a1ff1063741f6e5569feb44245785c9f472799b2 | |
| ToppCell | critical-Myeloid-Non-resident_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.29e-05 | 199 | 50 | 4 | 193325768b17d3123ae855317f381a01088b5dac | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac|Lung / Manually curated celltypes from each tissue | 7.29e-05 | 199 | 50 | 4 | 1677aaee5b7f5f262e27df5d9f1bdf6e21e3d804 | |
| ToppCell | COVID-19-Myeloid-MoAM3,_VCAN|COVID-19 / Condition, Lineage and Cell class | 7.29e-05 | 199 | 50 | 4 | aba0b833e44fe42625fac91466f6ebaa8e786d3b | |
| ToppCell | Control-Control-Lymphocyte-B-B_memory|Control / Disease, condition lineage and cell class | 7.29e-05 | 199 | 50 | 4 | 76976d5f79f324a6c488161847c50f207361d6c6 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Alveolar_macrophages|Lung / Manually curated celltypes from each tissue | 7.29e-05 | 199 | 50 | 4 | eec1b086e5e8b9b0e1770dd269ca903f713d99a8 | |
| ToppCell | COVID-19-Myeloid-MoAM3,_VCAN|Myeloid / Condition, Lineage and Cell class | 7.29e-05 | 199 | 50 | 4 | 80f70c53e892fb692ef655662732e16e2c03ac8e | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.44e-05 | 200 | 50 | 4 | c30da72c3581d384b76c95f5989e32a36d783ef3 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.44e-05 | 200 | 50 | 4 | 09bac15df511687ff336c1e7a67d980c6c281f79 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pdgfa_(Mural.Rgs5Acta2.Pdgfa)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.85e-04 | 114 | 50 | 3 | 2cc5d2da5573650c5232a01e2d2128082c4bffcb | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pdgfa_(Mural.Rgs5Acta2.Pdgfa)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.85e-04 | 114 | 50 | 3 | fceb7cc590a47380145fc0d854c9f2350dbb0a59 | |
| ToppCell | Control-B_memory-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.64e-04 | 124 | 50 | 3 | 3e987915026f503e8d072a837b6e7a34252e5c63 | |
| ToppCell | mild-Myeloid-CD14_Monocytes_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.00e-04 | 128 | 50 | 3 | 7a0a7af930e9050d473390fe9827f96fd597f790 | |
| ToppCell | mild-Myeloid-CD14_Monocytes_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.57e-04 | 134 | 50 | 3 | 8ba1f8d0af63bb7a802a002e72fe181b203cb451 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.67e-04 | 135 | 50 | 3 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | Control-B_memory-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.77e-04 | 136 | 50 | 3 | 94f23bef50c0beb54ed39b1a4b340f7aec4e75cd | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.64e-04 | 144 | 50 | 3 | 75b16adfbe84f69376e6566d531ba7919d5c5192 | |
| ToppCell | Epithelial-B_(AT1-AT2-progenitors)|World / shred on cell class and cell subclass (v4) | 5.87e-04 | 146 | 50 | 3 | 4511916904c1fac252cb68e871b782207f8137b3 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.10e-04 | 148 | 50 | 3 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-04 | 149 | 50 | 3 | 61d84838a841ed2d6b8c5f86d423a4e6b3dcc9cb | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.22e-04 | 149 | 50 | 3 | 2cd860b96ed4be4d26844085d464961c1418054a | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.72e-04 | 153 | 50 | 3 | 9f0607a88d5f8a2c128a2ff64dfbc986212f13b2 | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.85e-04 | 154 | 50 | 3 | 1e088b0d4a44267f46a9b643f46a1aba784686b1 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.98e-04 | 155 | 50 | 3 | 498e52e2364ff44d3c0c707ba22468217031f5bd | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 7.51e-04 | 159 | 50 | 3 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_Cytotoxic_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.51e-04 | 159 | 50 | 3 | 2060e7ed5627976b48fea4a2328762b6fa308db1 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.65e-04 | 160 | 50 | 3 | 731def6d82814ebac1a400bc7aea5f6da43ec960 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.65e-04 | 160 | 50 | 3 | cf27b4ac4d0caa6f9b068dc8ea93472470a01a4d | |
| ToppCell | Mild-MAIT|Mild / Disease group and Cell class | 7.79e-04 | 161 | 50 | 3 | 0c1a04485708d5302600cdc2d7dac1cb76b4033a | |
| ToppCell | tumor_Lung-Myeloid_cells-Pleural_Mac|tumor_Lung / Location, Cell class and cell subclass | 7.93e-04 | 162 | 50 | 3 | 9ac3242511315224ed94582aca9e9a3786cd01a0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.93e-04 | 162 | 50 | 3 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.07e-04 | 163 | 50 | 3 | d7057ae155058a13f3d7c3db5c7fbc3bb2b69376 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.07e-04 | 163 | 50 | 3 | 55fd4f21c7a8bea031fb6f7f2c8cc1ff42b00d79 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.22e-04 | 164 | 50 | 3 | 057ca87847373eff7fe97dd9f4358509e66ca4c3 | |
| ToppCell | severe-unassigned|severe / disease stage, cell group and cell class | 8.36e-04 | 165 | 50 | 3 | f9ddd547992fec065d539a1d0305acba8fc7d79c | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.36e-04 | 165 | 50 | 3 | f6887c64af0f26e33316bc5587487e24d76ece2a | |
| ToppCell | Mild/Remission-B_memory-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.51e-04 | 166 | 50 | 3 | 03e1a369d8a83b814def07e29cabb023226b4828 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 8.51e-04 | 166 | 50 | 3 | 8de8f388f24436b84e19ef460476fdbda4d16abf | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.51e-04 | 166 | 50 | 3 | 01544c851588f1cde05d6700c3d1167f70a0fbd5 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.51e-04 | 166 | 50 | 3 | 575c325db88d6909cdf0d5e664bd9098b89d4401 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.51e-04 | 166 | 50 | 3 | c22a97353f7eb084f768c13d7767a80b30f05043 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-pDC|Liver / Manually curated celltypes from each tissue | 8.51e-04 | 166 | 50 | 3 | 24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44 | |
| ToppCell | CV-Mild-6|CV / Virus stimulation, Condition and Cluster | 8.66e-04 | 167 | 50 | 3 | cf2ed0b6d17a16f9a2318879ce8856d5983ad3cf | |
| ToppCell | IIH-naiveBc|IIH / Condition, Cell_class and T cell subcluster | 8.81e-04 | 168 | 50 | 3 | 8450ed6720d308c711dfbc76652e5821be7b8e93 | |
| ToppCell | IIH-naiveBc-|IIH / Condition, Cell_class and T cell subcluster | 8.81e-04 | 168 | 50 | 3 | 27b500f79aedc4669988670c92ff1a47dcbdf2a0 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.12e-04 | 170 | 50 | 3 | 02f0be0aab8ba2d35a83238609352ef3677511c9 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-04 | 171 | 50 | 3 | 0385d5834ae16bbb0c6a68893fec60e4dd1e478d | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-04 | 171 | 50 | 3 | a3e3fe0cbab21abb178c482f5951e576529f7e30 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.59e-04 | 173 | 50 | 3 | 45808cf69122c16b9d2b5ffa06d15392c55954b7 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 9.59e-04 | 173 | 50 | 3 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.59e-04 | 173 | 50 | 3 | 7fa9dbcb258c3ab974490063951620e2def03db1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.59e-04 | 173 | 50 | 3 | b002b22f9968b5967d29fe0eab4e796d87b355fa | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-04 | 174 | 50 | 3 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.75e-04 | 174 | 50 | 3 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Myeloid-new-cluster|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-04 | 174 | 50 | 3 | 718e14d9a4264456459bec4c062c94c3a848d43a | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.91e-04 | 175 | 50 | 3 | 1b3510e9078eec7cfc5805043e435e9e5e0f0877 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.91e-04 | 175 | 50 | 3 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.91e-04 | 175 | 50 | 3 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-04 | 175 | 50 | 3 | 61fdafba120fbda063d4dc05263d6f8d1dcab1e1 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-04 | 175 | 50 | 3 | 8de8031fdf2af187642833feb80caa64932897cf | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.91e-04 | 175 | 50 | 3 | eaec7fda07a9537d067ca13b607a8ab201caa7c4 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.01e-03 | 176 | 50 | 3 | f3a54038cde58326f1caed96ecca33c141bcc8b3 | |
| ToppCell | Mild/Remission-B_memory-6|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.02e-03 | 177 | 50 | 3 | 8f2ce5ffc94ca90412cb6899629f322dc778215c | |
| ToppCell | Severe-B_memory-6|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.02e-03 | 177 | 50 | 3 | c4c3511782d5febd0c8b369eebe9355ad3c3bcf2 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-03 | 177 | 50 | 3 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-03 | 178 | 50 | 3 | 6ad46b0720298bcb927fd53468bb4ea0c199ad35 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-03 | 178 | 50 | 3 | be1d991c5a0a5be22f14f57d34ee1330f1a12963 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-03 | 178 | 50 | 3 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-03 | 178 | 50 | 3 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-03 | 178 | 50 | 3 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.06e-03 | 179 | 50 | 3 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | COVID-19_Moderate-B_intermediate|World / disease group, cell group and cell class | 1.07e-03 | 180 | 50 | 3 | bd81b87a6dc81e5ab4a6c948eb0c80f14401a6a7 | |
| ToppCell | control-Lymphoid-B_cell|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.09e-03 | 181 | 50 | 3 | e414303bb90e5fe7b667c2acf9a50f8694b90e54 | |
| Disease | Diarrhea | 1.35e-04 | 11 | 47 | 2 | C0011991 | |
| Disease | Drug Use Disorders | 8.25e-04 | 115 | 47 | 3 | C0013222 | |
| Disease | Drug Dependence | 8.25e-04 | 115 | 47 | 3 | C1510472 | |
| Disease | Drug habituation | 8.25e-04 | 115 | 47 | 3 | C0013170 | |
| Disease | Substance Dependence | 8.25e-04 | 115 | 47 | 3 | C0038580 | |
| Disease | Substance Use Disorders | 8.25e-04 | 115 | 47 | 3 | C0038586 | |
| Disease | Substance-Related Disorders | 8.25e-04 | 115 | 47 | 3 | C0236969 | |
| Disease | Drug abuse | 8.25e-04 | 115 | 47 | 3 | C0013146 | |
| Disease | Organic Mental Disorders, Substance-Induced | 8.25e-04 | 115 | 47 | 3 | C0029231 | |
| Disease | Prescription Drug Abuse | 8.25e-04 | 115 | 47 | 3 | C4316881 | |
| Disease | Substance abuse problem | 8.46e-04 | 116 | 47 | 3 | C0740858 | |
| Disease | stimulant use measurement | 9.14e-04 | 28 | 47 | 2 | EFO_0600076 | |
| Disease | oral microbiome measurement | 2.05e-03 | 42 | 47 | 2 | EFO_0801229 | |
| Disease | alcohol dependence measurement | 3.49e-03 | 55 | 47 | 2 | EFO_0007835 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KFSKMKTAYEEVTTE | 876 | Q8IVF6 | |
| SVLTTKKTYSDDKEM | 2156 | P13611 | |
| FSKMKTAYEDVTTEL | 886 | A2A2Z9 | |
| VTKMVDERTDYLTKS | 896 | Q9UKA4 | |
| EESVTESTKQITYMI | 171 | Q8IWG1 | |
| TESYKETLHKTMVTR | 911 | P98175 | |
| DSTMVLLYTSVDTKK | 376 | P25092 | |
| KTSVEEMIASTAYLE | 341 | Q8N612 | |
| TTMEKEKVSSVFYIT | 266 | Q9GZM6 | |
| VDSTKDSYVLVSKMD | 171 | O15480 | |
| TDYMTSLKKEVKTSS | 1821 | Q5T1H1 | |
| MVKFIKETYLDTVTE | 271 | Q8IV33 | |
| YITKVMSKSSAEVIA | 251 | Q16555 | |
| YVMIDDISELTKDST | 3231 | Q9UPA5 | |
| IKYSKLLSMEVSDTS | 551 | Q8IWD5 | |
| SSKMDKYETEESSVA | 436 | Q9P2D6 | |
| KITEMITVVQTYSTL | 371 | Q96JB1 | |
| KTKMIYTAATTEETI | 316 | Q14973 | |
| AVTSRMVKTYEKLTE | 321 | P05107 | |
| KVTVEEVMTTTAYLD | 326 | Q05DH4 | |
| KISVYTGKSETITDM | 171 | Q8IZF7 | |
| SMAVKTDSTTEVIYE | 501 | Q8NEU8 | |
| TDSRVKTEDTTAIYM | 421 | Q86Z14 | |
| TYLSKTLTEEEAKMI | 536 | Q5TBA9 | |
| MEELKILSDTYTVEK | 281 | Q9H6D7 | |
| MTSTLEYKTTKADIQ | 201 | Q13740 | |
| TTESEVMKYITSLNE | 76 | P11586 | |
| KTKTIEEVYMSSIES | 436 | Q8IWE2 | |
| SSLVIDKESEVYKML | 186 | O00151 | |
| SLKDAVITVMYTAVT | 266 | Q9P1Q5 | |
| LTTVKEKASAVMYTA | 266 | Q8NGA1 | |
| ETLKNMVKSTVSYIS | 271 | O75691 | |
| KDYSVTVSSLDEMVV | 721 | Q14DG7 | |
| TIMEKSETELKDTYA | 541 | Q13200 | |
| ITSLISSVVKMKDSY | 561 | Q13018 | |
| YLETKKVTASMEEVL | 346 | Q5VX52 | |
| IDVKRSYVTMTATKI | 286 | Q9UHD1 | |
| SIYESVSETITKMLK | 261 | Q15846 | |
| YIMISKDTTAKEVVI | 621 | Q9Y4G8 | |
| SSETTKFYMTEIIIQ | 221 | Q7Z6J8 | |
| TSTESMDFLKYVVDK | 866 | O43847 | |
| EISSKEMTVTYIEAS | 296 | P13686 | |
| MVGSEVYSTEIKKTE | 96 | Q9Y265 | |
| MTESFKIKTAYEESL | 641 | Q9H6N6 | |
| GKVSVEYTEKMVSIS | 206 | Q92979 | |
| TVRDYIQSTMETEKT | 121 | Q96S44 | |
| YSKAKMESSSVSVVS | 311 | Q5SVZ6 | |
| KDSVYKRSMTEGSTV | 1471 | Q9BXT5 | |
| TTVLATKTAEYSEMV | 1326 | Q5THJ4 | |
| TTSTYTMEVERLKKE | 951 | Q9ULV0 | |
| EVFTETTYESTKMIE | 691 | Q14324 |